Difference between revisions of "Team:Uppsala/Naphthalene"
Oskarwestlin (Talk | contribs) |
Oskarwestlin (Talk | contribs) |
||
Line 78: | Line 78: | ||
Using BL21DE3 as well as the standard DH5α was motivated by its prominent protein-expressing capabilities. It should hence be better at breaking down naphthalene. Throughout the process, gel electrophoresis was used to confirm the lengths of the fragments. | Using BL21DE3 as well as the standard DH5α was motivated by its prominent protein-expressing capabilities. It should hence be better at breaking down naphthalene. Throughout the process, gel electrophoresis was used to confirm the lengths of the fragments. | ||
</p> | </p> | ||
− | <u><p> | + | <u><p>Mutagenesis of internal restriction sites</p></u> |
<p> | <p> | ||
As mentioned previously, the upper naphthalene pathway contains two PstI-sites. These were removed through site-directed mutagenesis. For each respective mutation site, an overlapping and complementary primer pair containing a silent mutation was designed. Prior to the first site-directed mutagenesis PCR, the primers were phosphorylated with T4 polynucleotide kinase. All remaining methylated DNA was subsequently digested using DpnI and the plasmid was recirculated. Thereafter, the second site-directed mutagenesis PCR utilizing the second set of primers was exerted with ligated product. The PCR product was once again recirculated and transformed into competent DH5α and BL21DE3 cells. | As mentioned previously, the upper naphthalene pathway contains two PstI-sites. These were removed through site-directed mutagenesis. For each respective mutation site, an overlapping and complementary primer pair containing a silent mutation was designed. Prior to the first site-directed mutagenesis PCR, the primers were phosphorylated with T4 polynucleotide kinase. All remaining methylated DNA was subsequently digested using DpnI and the plasmid was recirculated. Thereafter, the second site-directed mutagenesis PCR utilizing the second set of primers was exerted with ligated product. The PCR product was once again recirculated and transformed into competent DH5α and BL21DE3 cells. |
Revision as of 23:48, 18 September 2015
Naphthalene pathway
The Nah7-group has been working on extracting and characterizing the upper naphthalene-degrading pathway of the Nah7 plasmid from Pseudomonas putida G7. This will serve two purposes. First, it will break down the low-weight polycyclic aromatic hydrocarbon (PAH) naphthalene to the non-toxic product salicylate. Second, the produced salicylate will activate the PsaI/NahR promoter system, thus inducing the production of laccases and dioxygenases resulting in the degradation of heavier PAHs such as benzo(a)pyrene (BaP).
Introduction
Some bacteria have developed enzymatic pathways capable of degrading the toxic PAHs in order to utilize them as a carbon source. Naphthalene is one such PAH, and the PpG7 strain of P. putida is one such bacterium. P. putida is a class one safety level bacterium found mainly in soil. It grows optimally at room temperature and is considered non-pathogenic. The Nah7 plasmid of P. putida contains two pathways that together degrade naphthalene into carbon dioxide (Sota A. et al., 2006). The upper of these two pathways contains six enzymes that break down naphthalene to salicylate, and it is this upper pathway that we attempted to isolate and express in Escherichia coli. The enzymes, substrates and intermediates of the upper naphthalene degrading pathway can be found in fig.1.
The reason for excluding the lower pathway from our construct is that we are really interested in one of the intermediates of the breakdown, salicylate, as it can be used to induce the Psal promoter (BBa_K1031021). The NahR protein is continuously bound to the Psal promoter, and upon interaction with salicylate, transcription of the subsequent genes is induced. In our system, the gene products are a laccase, a dioxygenase and a fluorophore. In the presence of naphthalene, our pathway will produce salicylate and our laccase and dioxygenase genes will be expressed.
The sequence of interest, therefore, is an operon called the upper naphthalene pathway. The genetic sequence of the upper pathway is made up of ten genes and is approximately 8000 base pairs long and the entire Nah7 plasmid is 82,232 base pairs (Sota A. et al. 2006).
Methods
Growing Pseudomonas putida
The P. putida strain PpG7, acquired from Professor J. R. van der Meer, requires naphthalene to be supplied to the culture to ensure the bacteria does not rid itself of the plasmid. This was achieved by placing a small amount of naphthalene crystals in the lid of the agar plates of the cultures. We also constructed a contraption for growing liquid P. putida cultures, where naphthalene was placed in an open Eppendorf tube suspended in the E-flask above the culture.
Naphthalene is, as mentioned, a PAH and is thus carcinogenic and teratogenic. Hence, the chemical was handled with appropriate care and safety measures. All cultures containing naphthalene were kept in fume hoods and handled with gloves. We attempted to extract the plasmids directly from the liquid cultures, as this would provide a more pure and better template for our PCRs. However, since Nah7 has a very low copy-number in P. putida it was not possible to achieve a high enough DNA concentration. As such, a modified version of colony PCR was used. The cells were boiled prior to PCR amplification and the denaturation and annealing times were extended.
Isolation of sequence (PCR, primer design and insertion into DH5α)
Since the pathway was extracted through PCR, the primers were designed with an overhang in order to add a standardized iGEM ribosome binding site (RBS) sequence, as well as the standardized iGEM prefix and suffix. The prefix contains the restriction sites corresponding to the EcoRI and XbaI restriction enzymes. The suffix overhang, however, contained only one of the customary restriction sites, namely the SpeI site. This was due to the fact that the upper naphthalene pathway contains two endogenous PstI sites, preventing us from using that enzyme without digesting our sequence of interest.
Initially we designed several sets of primers to ensure that at least one pair would prove successful. We designed one forward primer (forw. 1 in figure 3) with the iGEM prefix and RBS as described above. Moreover, we designed one forward primer (forw.2 in figure 3) with just the prefix and no RBS, with the purpose of lifting the pathway with its native promoter and RBS. The same reverse primer (rev. 1 in figure 3) was used for both of these forward primers.
Furthermore, we designed primers for lifting our sequence in two separate fragments. Thus, we also designed a reverse primer (rev. 2 in figure 3) starting in the middle of our sequence, as well as a forward primer (forw. 3 in figure 3) starting at the same point. After testing all of these primers, we could conclude that the first pair described above was the most apt.
Initially we had some trouble with the PCR amplification, as the very long primers had a tendency to form secondary structures. This was abated by adding various concentrations of DMSO and GC buffer to the mastermix.
Assembly with promoter
The PCR product was inserted into the standard iGEM plasmid backbone pSB3C5 and the ligation product was used to transform E.coli of the strain DH5α, which were subsequently streaked on plates containing chloramphenicol. The plasmid backbone was chosen because of its low to medium copy number, which matches the copy number of the Nah7 plasmid in P.putida. This is important to ensure that the level of overexpression does not interfere with important cell functions.
Successfully transformed cells were once again streaked on plates and grown overnight, followed by a plasmid extraction. The extracts were assembled with the two promoters (BBa_J23110) and (BBa_J23101) using the iGEM standard assembly protocol. E.coli of the two strains DH5α and BL21DE3 were then transformed with the ligated plasmids. Using BL21DE3 as well as the standard DH5α was motivated by its prominent protein-expressing capabilities. It should hence be better at breaking down naphthalene. Throughout the process, gel electrophoresis was used to confirm the lengths of the fragments.
Mutagenesis of internal restriction sites
As mentioned previously, the upper naphthalene pathway contains two PstI-sites. These were removed through site-directed mutagenesis. For each respective mutation site, an overlapping and complementary primer pair containing a silent mutation was designed. Prior to the first site-directed mutagenesis PCR, the primers were phosphorylated with T4 polynucleotide kinase. All remaining methylated DNA was subsequently digested using DpnI and the plasmid was recirculated. Thereafter, the second site-directed mutagenesis PCR utilizing the second set of primers was exerted with ligated product. The PCR product was once again recirculated and transformed into competent DH5α and BL21DE3 cells.
To view our results from this part of the project, please click here.
References
Masahiro Sota, Hirokazu Yano, Akira Ono, Ryo Miyazaki, Hidenori Ishii, Hiroyuki Genka,2 Eva M. Top, and Masataka Tsuda. Genomic and Functional Analysis of the IncP-9 Naphthalene-Catabolic Plasmid Nah7 and Its Transposon Tn4655 Suggests Catabolic Gene Spread by a Tyrosine Recombinase. J Bacteriol. 2006 Jun; 188(11): 4057–4067. doi: 10.1128/JB.00185-06